A proportion of T/myeloid MPAL cases have immunophenotypic features that overlap with those of ETP‐ALL, and the only difference is MPO positivity in T/myeloid MPAL and MPO negativity in ETP‐ALL [1, 7]. This evidence concerns the gene MPO and acute lymphoblastic leukemia.